Tryptamine reports positive interim analysis for its phase 2a clinical study of oral psilocybin formula TRP-8802 in patients with IBS. Don't miss out on the headlines from Stockhead. Followed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback